NCT07780890Recruiting
A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
Source: ClinicalTrials.gov · Last updated 25 Aug 2026
Brief summary (registry, in English)
The overall goal of this study is to develop Brillouin microscope as a novel tool for measuring biomechanical and hydration properties of human tissues in vivo.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 90 (estimated)
- First submitted
- 18 Aug 2026
- Start date
- 18 Aug 2026
- Primary completion date
- 1 Sept 2027
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Glaucoma
- NCT number
- NCT07780890
What you commit to
- Study type: Observational
- Planned participants: 90
- From 18 Aug 2026 to the primary completion date, 1 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of refractive or cataract surgery
- History of ocular disease
- Active non-ophthalmic systemic disease
Who the study is looking for
- Healthy volunteers with normal eyes
- Visual acuity between +2 to -6 diopters
Age in the registry: 20 years to 79 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Brigham Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.